Related Experiment Video
Updated: Sep 10, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Cost-effectiveness of CMR over MPS-SPECT: a systematic review of recent trends for diagnosing CAD
Ben Kluge1, James Harris2, Irene Sánchez-Collado2
1Bayer AG Pharmaceuticals, Berlin, Germany.
Insights
Cardiovascular magnetic resonance (CMR) imaging is often more cost-effective than myocardial perfusion scintigraphy (MPS-SPECT) for diagnosing coronary artery disease (CAD). Further research is needed to confirm these economic benefits across various healthcare settings.
Area of Science:
- Cardiology
- Health Economics
- Diagnostic Imaging
Background:
- The economic impact of cardiovascular magnetic resonance (CMR) and myocardial perfusion scintigraphy (MPS-SPECT) for diagnosing coronary artery disease (CAD) is not well-established.
- Symptomatic individuals with low-to-intermediate pre-test probability (PTP) of CAD require effective non-invasive diagnostic tools.
Purpose of the Study:
- To compare the cost-effectiveness of CMR and MPS-SPECT as first-line diagnostic modalities for CAD.
- To evaluate the health economic impacts of CMR versus MPS-SPECT in diagnosing symptomatic patients with low-to-intermediate PTP of CAD.
Main Methods:
- A systematic review of multiple databases (MEDLINE, Embase, Cochrane, NHS EED) was conducted.
- Studies published between January 1992 and January 2023, focusing on the USA, UK, Germany, France, Italy, Japan, and China, were included.
- Risk of bias was assessed using the Drummond checklist.
Main Results:
- In the USA, CMR was consistently more cost-effective than MPS-SPECT for low-to-intermediate PTP CAD patients, with lower resource use and total costs.
- In Europe, CMR demonstrated cost-effectiveness in Germany, while the UK showed mixed cost savings with increased quality-adjusted life-years.
- Only thirteen reports were identified, with just three providing cost-effectiveness outcomes, indicating a need for more research.
Conclusions:
- Findings suggest that cost savings associated with CMR over MPS-SPECT for low-to-intermediate PTP CAD patients warrant prioritized investment.
- Further confirmatory research is essential due to the limited number of identified cost-effectiveness analyses.
Aims:
The health economic impacts of cardiovascular magnetic resonance (CMR) imaging and myocardial perfusion scintigraphy by single photon emission computed tomography (MPS-SPECT) as diagnostic modalities are not well understood. This review is based on a wider systematic review and aims to compare CMR and MPS-SPECT as first-line, non-invasive modalities for the diagnosis of symptomatic individuals with a low-to-intermediate pre-test probability (PTP) of coronary artery disease (CAD).
Materials And Methods:
We performed a systematic review of MEDLINE and Embase, MEDLINE In-process, the Cochrane Database of Systematic reviews and the Cochrane Central Register of Controlled Trials. Studies from January 1992 to January 2023 were included, if they were based in the UK, France, Germany, Italy, Japan, China, and/or the USA (published in any language). Risk of bias was assessed using the Drummond checklist.
Results:
Thirteen relevant reports were identified. In the USA, CMR was consistently cost-effective compared with MPS-SPECT for patients with a low-to-intermediate PTP of CAD; resource use and associated costs, as well as total costs, were lower. For patients with a low-to-intermediate PTP of CAD in Europe, CMR was cost-effective in Germany, while in the UK increases in quality-adjusted life-years were found but cost savings were mixed. This review found only 13 reports on the economic benefits of CMR over MPS-SPECT, with just three providing cost-effectiveness outcomes, highlighting the need for further research across different settings and perspectives.
Conclusion:
Overall, findings suggest that the cost savings from using CMR compared with MPS-SPECT for patients with a low-to-intermediate PTP of CAD support prioritized investment; however, confirmatory research is needed given the limited number of cost-effectiveness analyses identified in this review.
More Related Videos
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests